Ring Therapeutics Company
Ring Therapeutics company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy.
Technology:
Others
Industry:
Gene therapy
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2017
Employees Number:
11-50
Funding Status:
Early Stage Venture
Total Funding:
167000000
Estimated Revenue:
Less than $1M
Last Funding Type:
Series B
Register and Claim Ownership